1. Wu, Xuan, Chen, Chen, Han, Tiaotiao, Qiao, Longwei, Zheng, Qiping. 2023. Stat5a promotes Col10a1 gene expression during chondrocyte hypertrophic differentiation. In American journal of translational research, 15, 4006-4019. doi:. https://pubmed.ncbi.nlm.nih.gov/37434818/
2. Zhang, Mingdi, Chen, Hongliang, Wang, Maoli, Bai, Fang, Wu, Kejin. . Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer. In Bioscience reports, 40, . doi:10.1042/BSR20193286. https://pubmed.ncbi.nlm.nih.gov/32043519/
3. Chen, Chen, Wu, Xuan, Han, Tiaotiao, Qiao, Longwei, Zheng, Qiping. 2023. Mef2a is a positive regulator of Col10a1 gene expression during chondrocyte maturation. In American journal of translational research, 15, 4020-4032. doi:. https://pubmed.ncbi.nlm.nih.gov/37434855/
4. Xu, Qiaodong, Zheng, Jieting, Su, Zegeng, Chen, Binlie, Gu, Songgang. 2023. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma. In BMC gastroenterology, 23, 397. doi:10.1186/s12876-023-03045-2. https://pubmed.ncbi.nlm.nih.gov/37974070/
5. Yi, Qiang, Zhu, Gangfeng, Zhu, Weijian, Yang, Kuan, Zhong, Jinghua. 2024. Oncogenic mechanisms of COL10A1 in cancer and clinical challenges (Review). In Oncology reports, 52, . doi:10.3892/or.2024.8821. https://pubmed.ncbi.nlm.nih.gov/39392043/
6. Wang, Xiaoming, Bai, Yunjin, Zhang, Facai, Wei, Xin, Han, Ping. 2023. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation. In Frontiers in immunology, 14, 955949. doi:10.3389/fimmu.2023.955949. https://pubmed.ncbi.nlm.nih.gov/37006317/
7. Xu, Shengxian, Liu, Dongze, Qin, Zheng, Xu, Yong, Zhang, Hongtuan. 2023. Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer. In Aging, 15, 15134-15160. doi:10.18632/aging.205337. https://pubmed.ncbi.nlm.nih.gov/38147021/
智鼠故事 
